Tetracycline
In clinical developmentAlso known as Ala-Tet, Brodspec, Emtet-500, Pylera+17 more
Ala-Tet, Brodspec, Emtet-500, Pylera, Robitet 500, Tetra 500, Tetracap, Tetracon, Tetrazyklin, Tsiklomitsin, Viabecline, Vitastem, Achromycin, Panmycin, Sumycin, Topicycline, Tetracyclin, Tétracycline, (4S,4aS,5aS,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide, Tetracycline Hydrochloride, Tetracyclinum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Helicobacter Pylori Eradication and Follow-up in Zhongshan Hospital
Sanitation, Water, and Instruction in Face-washing for Trachoma I/II
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Pharmacology & targets
Known molecular targets and mechanisms supported by curated pharmacology databases.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Helicobacter Pylori Eradication and Follow-up in Zhongshan Hospital
Recent completions
Trials that read out recently, adding to the completed evidence base.
Sanitation, Water, and Instruction in Face-washing for Trachoma I/II
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Journals, researchers & institutions
- The Journal of clinical investigation1
- Benjamin LE1
- Golijanin D1
- Itin A1
- Keshet E1
- Pode D1
- The Hebrew University/Hadassah Medical School1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 3 of the same disease areas as Tetracycline in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials